dromlakhani Recommend against routine treatment of low androgen levels in specific conditions
STEP 1 — Gather Information
Collect history of hypopituitarism, adrenal insufficiency, bilateral oophorectomy, or pharmacological glucocorticoid use; document symptoms attributed to low androgen (e.g., fatigue, low libido); obtain baseline androgen levels if measured to confirm low levels.
STEP 2 — Rule In / Rule Out
If the woman has hypopituitarism, adrenal insufficiency, bilateral oophorectomy, or glucocorticoid-induced adrenal suppression, rule in that routine androgen therapy is not recommended; otherwise, rule out this recommendation and consider other indications such as HSDD.
STEP 3 — Classify or Stratify
Classify the specific etiology (hypopituitarism, adrenal insufficiency, surgical menopause, glucocorticoid) to tailor discussion of potential risks and alternative management strategies.
STEP 4 — Decide
Decide to withhold routine testosterone or DHEA therapy and instead address symptoms through evaluation of other causes and non‑hormonal interventions.
Clinical Guardrails / Mimics / Pitfalls
Do not prescribe androgen therapy based solely on low androgen levels in these conditions; avoid long‑term therapy without safety data; monitor for signs of androgen excess if a trial is considered; do not use androgen levels to diagnose a deficiency syndrome.
Concrete Clinical Example
A 48‑year‑old woman with prior bilateral oophorectomy reports decreased energy and libido; her clinician considers testosterone therapy; following this skill, routine androgen therapy is discouraged, and she is evaluated for thyroid dysfunction and mood disorders instead.
Source: Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline, Endocrine Society, American Society for Reproductive Medicine, American Congress of Obstetricians and Gynecologists, European Society of Endocrinology, International Menopause Society, 2014, https://doi.org/10.1210/jc.2014-2260